Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
R. Matthew Neff currently holds 151,102 shares of BIOANALYTICAL SYSTEMS INC (BASI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, R. Matthew Neff has been a net buyer of BASI stock. They have purchased $247.9K and sold $57.3K worth of shares.
R. Matthew Neff's most recent insider trade was on Dec 1, 2025, when they sold 2,000 shares at $0.89 per share.
R. Matthew Neff serves as Executive at BIOANALYTICAL SYSTEMS INC (BASI). They have executed 27 insider transactions totaling $305.2K over their tenure at the company.
R. Matthew Neff holds the position of Executive at BIOANALYTICAL SYSTEMS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
R. Matthew Neff has shown a buying trading pattern, with $247.9K in total purchases and $57.3K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by R. Matthew Neff was on Mar 12, 2020, when they purchased $45.6K worth of BASI shares. This transaction involved 12,000 shares at $3.80 per share.
R. Matthew Neff currently owns 151,102 shares of BIOANALYTICAL SYSTEMS INC (BASI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of R. Matthew Neff's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. R. Matthew Neff has 27 Form 4 filings on record as an insider at BIOANALYTICAL SYSTEMS INC.
Set alerts for R. Matthew Neff and 40,000+ other insiders.